Govt approves stepping up of Remdesivir Drug production -Governance Now

Govt approves stepping up of Remdesivir Drug production

Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3500 by the end of this week to fight against COVID.

| April 15, 2021

#Remdesivir #CovidVaccine #Corona #Coronavaccine #NationalPharmaceuticalPricingAuthority #DCGI #Vaccineexport

The government has reviewed the issue of availability of Remdesivir Drug and has decided to increase the production and decrease the price of the drug. The government has also issued a ban on its export. Remdesivir is the first drug approved by the FDA for treating the SARS-CoV-2 virus.

The review was done by Mansukh Mandaviya, Minister of State, For Ports, Shipping and Waterways (Independent Charge) and Chemicals & Fertilizers, Government of India in meetings with the all-existing manufacturers of the Remdesivir drug and other stakeholders on 12th and 13th April 2021.

As an additional measure, Remdesivir, API and formulation were placed under the export ban by DGFT to increase the supply of Remdesivir in the domestic market. On Government intervention, Remdesivir supplies of approximately 4 lakh vials meant for export is being diverted by manufacturers to fulfil the domestic requirement. EOU/SEZ units are also being enabled to supply to the domestic market.

Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3500 by the end of this week to fight against COVID. Manufactures of Remdesivir have been directed to give priority to fulfil hospital/institutional level supplies. National Pharmaceutical Pricing Authority (NPPA) is continuously monitoring the availability of Remdesivir.

Also, DCGI has directed enforcement authorities of states and central government to take immediate action on the incidence of black-marketing, hoarding and overcharging of Remdesivir.

The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month. Fast-track approval has been given for seven additional sites having the production capacity of 10 Lakh vials /month to six manufacturers. Another 30 lakh vials/month production is lined up. This would ramp up the production capacity for manufacturing to around 78 lakh vials/month.

Comments

Other News

India gets the first hydrogen train

Prime minister Narendra Modi on Friday laid the foundation stone and dedicated to the nation various development projects worth around ₹14,700 crore in Jind, Haryana. The PM positioned the city as a shining reflection of the good governance model. Emphasizing that the entire Haryana

Climate change is stealing sleep

Climate change has at least doubled the temperature-related sleep loss across 1,338 major cities worldwide over the past five decades, highlighting an emerging but often overlooked public health consequence of rising global temperatures. A new study by Climate Central estimates that between 2020 and

Cabinet approves Mobile Phone Manufacturing Scheme

The union cabinet chaired by PM Narendra Modi has approved the Mobile Phone Manufacturing Scheme (MPMS) with a budgetary outlay of Rs 62,500 crore. It aims to further scale up the production, deepen domestic value addition, strengthen supply chain resilience, enhance global competitiveness. It

Building infrastructure is only half the job

Recent stories of stolen railway wires, disappearing communication towers and missing public infrastructure are often treated as bizarre law-and-order failures of India. Yet they raise a more fundamental question. Why does the State often discover the disappearance of a public asset only after it has alrea

New Delhi’s Indo-Pacific strategy enters a new phase

India appears to be investing fresh dynamism in its Indo-Pacific strategy. At the time when the US, under president Donald Trump, has adopted a conciliatory approach towards China and has changed the name of America’s Indo-Pacific Command to just Pacific Command, India has quietly moved towards con

CAG flags major fiscal lapses in Maharashtra

Maharashtra`s fiscal management has come under sharp scrutiny after the Comptroller and Auditor General (CAG) of India, in its State Finances Audit Report for 2024-25, flagged significant budgetary inefficiencies, accounting irregularities, understatement of key fiscal indicators and widespread governanc